Abstract
The main objectives of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) are to harmonise breakpoints for antimicrobial agents in Europe, and to act as the breakpoint committee for the European Medicines Agency (EMEA) during the registration of new antimicrobial agents. Detailed EUCAST procedures for harmonising and setting breakpoints for antimicrobial agents are available on the EUCAST website. Beginning with the current issue, a series of EUCAST Technical Notes will be published in CMI, based on the rationale documents produced by EUCAST for each of the antimicrobial agents studied, with the aim of highlighting important background information underlying decisions on breakpoints made by EUCAST. © 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.
Author supplied keywords
Cite
CITATION STYLE
Kahlmeter, G., Brown, D. F. J., Goldstein, F. W., MacGowan, A. P., Mouton, J. W., Odenholt, I., … Stetsiouk, O. (2006). European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. Clinical Microbiology and Infection. Blackwell Publishing Ltd. https://doi.org/10.1111/j.1469-0691.2006.01454.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.